References
- HIV/ADS Surveillance in Europe. Mid-year report 2003; 69. Table 3, p. 19.
- Strathdee S, Sharman S. The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health 2003; 80(4 Suppl 3)7–14
- Battegay M, Bucher H, Vernazza P. Sexual risk behaviour in HIV-infected injection drug users. Clinical Infectious Diseases 2004; 38: 1175–7
- Hurley S, Jolley D, Kaldor J. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 1997; 349: 1797–1800
- Metzger D, Navaline H. HIV prevention among injection drug users: the need for integrated odels. The New York Academy of Medicine 2003; 80: No. 4
- Amundsen E, Eskild A, Stigum H, Smith E, Aalen O. Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users. European Journal of Public Health 2003; 13: 252–8
- Rhodes T, Ball A, Stimson GV, Kobyschcha Y, Fitch C, Pokrovsky V, et al. HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics. Addiction 1999; 94: 1323–36
- Stimson GV, Jones S, Chalmers C, Sullivan D. A short questionnaire (IRQ) to assess injecting risk behaviour. Addiction 1998; 93: 337–47
- Harvey E, Strathdee SA, Patrick DM, Ofner M, Archibald CP, Eades G, O'Shaughnessy MV. A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British Columbia. AIDS Care 1998; 10: 313–21
- McLellan T, Kushner H, Metzger D, Peters F. The fifth edition of Addiction Severity Index. Journal of Substance Abuse Treatment 1992; 9: 199–213
- Andréasson S, Lindström U, Armelius BÅ, Larsson H, Berglund M, Frank A, et al. ASI a way to interview clients with substance abuse. Cus skrift 1996; 1: 1–82
- Diaz T, Des Jarlais D, Vlahov D, Perlis T, Edwards D, Friedman S, et al. Factors associated with prevalent hepatitis C: differences among young injection drug users in lower and upper Manhattan. American Journal of Public Health 2001; 91: 23–30
- Des Jarlais D, Perlis T, Arasteh K, Hagan H, Milliken J, Braine N, et al. Altruism and partner restriction in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990–2201. J Acquir Syndr Immune Defic 2004; 35: 158–66
- Kwiatkowski C, Corsi K, Booth R. The association between hepatitis C virus status and risk behaviours in injecting drug users. Addiction 2002; 97: 1289–97
- Centers for Disease Control and Prevention. Updated US Public Health Service Guidelines for the management of occupational exposures to HBV, HCV and HIV and recommendations for post exposure prophylaxis. MMVR 2001; 50: 6–7
- Thorpe L, Ouellet L, Hershow R, Bailey S, Williams I, Williamson J, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology 2002; 155: 645–53
- Wejstål R, Alaeus A, Fischler B, Reichard O, Uhnoo I, Weiland O. Chronic hepatitis C: Updated Swedish consensus. Scandinavian Journal of Infectious Diseases 2003; 35: 445–51